[{"address1": "1150 Veterans Boulevard", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "925 407 1049", "website": "https://www.nkartatx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. The company's lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis. It has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.", "fullTimeEmployees": 157, "companyOfficers": [{"maxAge": 1, "name": "Mr. Paul J. Hastings", "age": 64, "title": "CEO & Director", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 979777, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Greg  Mann", "title": "Vice President of Public Affairs and Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shawn  Rose M.D., Ph.D.", "title": "Chief Medical Officer and Head of Research & Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 6, "overallRisk": 7, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.2, "open": 2.2, "dayLow": 2.19, "dayHigh": 2.44, "regularMarketPreviousClose": 2.2, "regularMarketOpen": 2.2, "regularMarketDayLow": 2.19, "regularMarketDayHigh": 2.44, "payoutRatio": 0.0, "beta": 0.727, "forwardPE": -1.3238636, "volume": 933799, "regularMarketVolume": 933799, "averageVolume": 515298, "averageVolume10days": 564150, "averageDailyVolume10Day": 564150, "bid": 2.3, "ask": 2.38, "bidSize": 1, "askSize": 1, "marketCap": 165487072, "fiftyTwoWeekLow": 1.31, "fiftyTwoWeekHigh": 6.628, "fiftyDayAverage": 1.9355, "twoHundredDayAverage": 2.123775, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -83131136, "profitMargins": 0.0, "floatShares": 54676123, "sharesOutstanding": 71024496, "sharesShort": 8079122, "sharesShortPriorMonth": 7535383, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.113900006, "heldPercentInsiders": 0.05016, "heldPercentInstitutions": 0.87217003, "shortRatio": 14.5, "shortPercentOfFloat": 0.1509, "impliedSharesOutstanding": 70957600, "bookValue": 4.835, "priceToBook": 0.48190278, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -109239000, "trailingEps": -1.46, "forwardEps": -1.76, "enterpriseToEbitda": 0.697, "52WeekChange": -0.55278313, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 2.33, "targetHighPrice": 18.0, "targetLowPrice": 8.0, "targetMeanPrice": 12.4, "targetMedianPrice": 12.0, "recommendationMean": 1.66667, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 334040992, "totalCashPerShare": 4.515, "ebitda": -119234000, "totalDebt": 78542000, "quickRatio": 27.602, "currentRatio": 27.602, "debtToEquity": 21.959, "returnOnAssets": -0.1602, "returnOnEquity": -0.26944, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "NKTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "epsTrailingTwelveMonths": -1.46, "epsForward": -1.76, "epsCurrentYear": -1.35667, "priceEpsCurrentYear": -1.7174404, "fiftyDayAverageChange": 0.3944999, "fiftyDayAverageChangePercent": 0.20382324, "twoHundredDayAverageChange": 0.20622492, "twoHundredDayAverageChangePercent": 0.097103, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-07-10", "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1755299560, "regularMarketTime": 1755288000, "exchange": "NMS", "messageBoardId": "finmb_544531597", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1594387800000, "shortName": "Nkarta, Inc.", "longName": "Nkarta, Inc.", "regularMarketChangePercent": 5.90909, "regularMarketPrice": 2.33, "postMarketChangePercent": 2.14593, "postMarketPrice": 2.38, "postMarketChange": 0.0500002, "regularMarketChange": 0.13, "regularMarketDayRange": "2.19 - 2.44", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 515298, "fiftyTwoWeekLowChange": 1.02, "fiftyTwoWeekLowChangePercent": 0.77862597, "fiftyTwoWeekRange": "1.31 - 6.628", "fiftyTwoWeekHighChange": -4.298, "fiftyTwoWeekHighChangePercent": -0.6484611, "fiftyTwoWeekChangePercent": -55.278313, "earningsTimestampStart": 1763064000, "earningsTimestampEnd": 1763064000, "isEarningsDateEstimate": true, "displayName": "Nkarta", "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]